Pfizer Buys Allergan in $160B Deal That Will Slash Its U.S. Taxes
Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world's largest drug maker.
It's also the largest so-called inversion, where an American corporation combines with a company headquartered in a country with a lower corporate tax rate, saving potentially millions each year in U.S. taxes.
Read more here :
http://www.nbcnews.com/business/business-news/pfizer-buys-allergan-160b-deal-will-slash-its-u-s-n468141
No comments:
Post a Comment